The Role of Pyroptosis in Ischemic and Reperfusion Injury of the Heart
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Pyroptosis in Ischemic and Reperfusion Injury of the Heart
Authors
Keywords
-
Journal
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
Volume -, Issue -, Pages 107424842110274
Publisher
SAGE Publications
Online
2021-07-16
DOI
10.1177/10742484211027405
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway
- (2020) Yuxiang Dai et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
- (2020) Antonio Abbate et al. CIRCULATION RESEARCH
- MiR-703 protects against hypoxia/reoxygenation-induced cardiomyocyte injury via inhibiting the NLRP3/caspase-1-mediated pyroptosis
- (2020) Xiaoliang Wei et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Myocardial ischaemia–reperfusion injury and cardioprotection in perspective
- (2020) Gerd Heusch Nature Reviews Cardiology
- Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction
- (2020) Max J. M. Silvis et al. Journal of Cardiovascular Translational Research
- The NLRP3 Inflammasome as a Critical Actor in the Inflammaging Process
- (2020) Maria Sebastian-Valverde et al. Cells
- NLPR3 Inflammasomes and Their Significance for Atherosclerosis
- (2020) Anastasia V. Poznyak et al. Biomedicines
- Anti-Inflammatory Therapy with Canakinumab for the Prevention of Hospitalization for Heart Failure
- (2019) Brendan M. Everett et al. CIRCULATION
- Calpain silencing alleviates myocardial ischemia-reperfusion injury through the NLRP3/ASC/Caspase-1 axis in mice
- (2019) Rong-Chuan Yue et al. LIFE SCIENCES
- Guidelines for evaluating myocardial cell death
- (2019) Paras K Mishra et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome
- (2019) Yochai Birnbaum et al. BASIC RESEARCH IN CARDIOLOGY
- The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction
- (2019) Rifeng Gao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial
- (2019) Derek J Hausenloy et al. LANCET
- Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis
- (2019) Yu Bian et al. ACTA PHARMACOLOGICA SINICA
- Interleukin‐18 in patients with acute coronary syndromes
- (2019) Axel Åkerblom et al. CLINICAL CARDIOLOGY
- MiR-149 Aggravates Pyroptosis in Myocardial Ischemia-Reperfusion Damage via Silencing FoxO3
- (2019) Jie Lin et al. MEDICAL SCIENCE MONITOR
- Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function
- (2018) Jonathon P. Audia et al. BASIC RESEARCH IN CARDIOLOGY
- The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway
- (2018) Helison Do Carmo et al. CARDIOVASCULAR DRUGS AND THERAPY
- Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome
- (2018) Soichi Sano et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection
- (2018) Hans Erik Bøtker et al. BASIC RESEARCH IN CARDIOLOGY
- NLRP3 deficiency accelerates pressure overload-induced cardiac remodeling via increased TLR4 expression
- (2018) Fangfang Li et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- A Membrane Potential- and Calpain-Dependent Reversal of Caspase-1 Inhibition Regulates Canonical NLRP3 Inflammasome
- (2018) Yifei Zhang et al. Cell Reports
- NF-κB-Gasdermin D (GSDMD) Axis Couples Oxidative Stress and NACHT, LRR and PYD Domains-Containing Protein 3 (NLRP3) Inflammasome-Mediated Cardiomyocyte Pyroptosis Following Myocardial Infarction
- (2018) Qian Lei et al. MEDICAL SCIENCE MONITOR
- Cardioprotective Effects of CYP-Derived Epoxy Metabolites of Docosahexaenoic Acid Involve Limiting NLRP3 Inflammasome Activation
- (2018) Ahmed M. Darwesh et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Selective Activation of Cannabinoid Receptor 2 Attenuates Myocardial Infarction via Suppressing NLRP3 Inflammasome
- (2018) Wen Yu et al. INFLAMMATION
- The Highly Selective Caspase-1 Inhibitor VX-765 Provides Additive Protection Against Myocardial Infarction in Rat Hearts When Combined With a Platelet Inhibitor
- (2017) Xi-Ming Yang et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- New and revisited approaches to preserving the reperfused myocardium
- (2017) Robert A. Kloner et al. Nature Reviews Cardiology
- Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
- (2017) Jianjin Shi et al. TRENDS IN BIOCHEMICAL SCIENCES
- NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective
- (2016) Ø. Sandanger et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia–reperfusion in the mouse
- (2016) Stefano Toldo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Pore-forming activity and structural autoinhibition of the gasdermin family
- (2016) Jingjin Ding et al. NATURE
- ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury
- (2016) Letteria Minutoli et al. Oxidative Medicine and Cellular Longevity
- Mitochondrially targeted Endonuclease III has a powerful anti-infarct effect in an in vivo rat model of myocardial ischemia/reperfusion
- (2015) Xi-Ming Yang et al. BASIC RESEARCH IN CARDIOLOGY
- Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion
- (2015) Wan-ting He et al. CELL RESEARCH
- Activation in M1 but not M2 Macrophages Contributes to Cardiac Remodeling after Myocardial Infarction in Rats: a Critical Role of the Calcium Sensing Receptor/NRLP3 Inflammasome
- (2015) Wenxiu Liu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Molecular Basis of Cardioprotection: Signal Transduction in Ischemic Pre-, Post-, and Remote Conditioning
- (2015) G. Heusch CIRCULATION RESEARCH
- Pyroptotic cell death defends against intracellular pathogens
- (2015) Ine Jorgensen et al. IMMUNOLOGICAL REVIEWS
- Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse
- (2015) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
- (2015) Jianjin Shi et al. NATURE
- Cyclosporine before PCI in Patients with Acute Myocardial Infarction
- (2015) Thien-Tri Cung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin 18 and extracellular matrix metalloproteinase inducer cross-regulation: implications in acute myocardial infarction
- (2015) Shuang-Lun Xie et al. Translational Research
- Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future
- (2014) Michael V Cohen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Differential Contribution of Monocytes to Heart Macrophages in Steady-State and After Myocardial Infarction
- (2014) Timo Heidt et al. CIRCULATION RESEARCH
- Nlrp3 plays no role in acute cardiac infarction due to low cardiac expression
- (2014) Willeke M.C. Jong et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Elevated Plasma IL-37, IL-18, and IL-18BP Concentrations in Patients with Acute Coronary Syndrome
- (2014) Qingwei Ji et al. MEDIATORS OF INFLAMMATION
- Unknown
- (2014) Ben Lu et al. MOLECULAR MEDICINE
- The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury
- (2013) Øystein Sandanger et al. CARDIOVASCULAR RESEARCH
- A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia–Reperfusion in the Mouse
- (2013) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Role of endogenous opioid peptides in the infarct size-limiting effect of adaptation to chronic continuous hypoxia
- (2013) Leonid N. Maslov et al. LIFE SCIENCES
- Progress report on new antiepileptic drugs: A summary of the Eleventh Eilat Conference (EILAT XI)
- (2012) Meir Bialer et al. EPILEPSY RESEARCH
- Interleukin-1β blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse
- (2012) Stefano Toldo et al. EXPERIMENTAL PHYSIOLOGY
- Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis
- (2012) Kenichi Shimada et al. IMMUNITY
- Platelet P2Y12 Blockers Confer Direct Postconditioning-Like Protection in Reperfused Rabbit Hearts
- (2012) Xi-Ming Yang et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention
- (2012) S. Ørn et al. JOURNAL OF INTERNAL MEDICINE
- The functions and regulation of the PTEN tumour suppressor
- (2012) Min Sup Song et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Deletion of the Innate Immune NLRP3 Receptor Abolishes Cardiac Ischemic Preconditioning and Is Associated with Decreased Il-6/STAT3 Signaling
- (2012) Coert J. Zuurbier et al. PLoS One
- Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury
- (2011) Masanori Kawaguchi et al. CIRCULATION
- Caspase-1-induced pyroptotic cell death
- (2011) Edward A. Miao et al. IMMUNOLOGICAL REVIEWS
- The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
- (2011) E. Mezzaroma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-18 as a Predictor of Future Events in Patients With Acute Coronary Syndromes
- (2010) Marianne Hartford et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Postconditioning and protection from reperfusion injury: where do we stand? * Position Paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology
- (2010) M. Ovize et al. CARDIOVASCULAR RESEARCH
- A Highly Potent and Selective Caspase 1 Inhibitor that Utilizes a Key 3-Cyanopropanoic Acid Moiety
- (2010) Matthew B. Boxer et al. ChemMedChem
- Interleukin-18 Levels on Admission Are Associated With Mid-Term Adverse Clinical Events in Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
- (2010) Yan Gao et al. International Heart Journal
- A role for mitochondria in NLRP3 inflammasome activation
- (2010) Rongbin Zhou et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More